ABOUT JAK-IN-3

Must a rise in AST or ALT of thrice the higher limit of usual or higher persist, withdrawal of cerivastatin sodium therapy is suggested.Rhabdomyolysis with renal dysfunction secondary to myoglobinuria happen to be noted with other HMG-CoA reductase inhibitors. This has not been reported with cerivastatin sodium to date. Cerivastatin therapy ought t